The Stock Exchange of Hong Kong Limited has issued a Director Unsuitability Statement and a public censure against Ms Zhang Xian, former CEO and executive director of China Tian Yuan Healthcare Group Limited. The investigation by the Listing Division found that Ms Zhang failed to respond to investigation and reminder letters, breaching the Listing Rules. As a result, she is deemed unsuitable for any director or senior management position within the company or its subsidiaries. It is crucial to note that a director’s obligation to cooperate with investigations does not expire upon resignation. These sanctions apply only to Ms Zhang and not to the company or other directors.
Statement of Disciplinary Action: https://www.hkex.com.hk/-/media/HKEX-Market/Listing/Rules-and-Guidance/Disciplinary-and-Enforcement/Disciplinary-Sanctions/2023/231026_SoDA.pdf
Resource: https://www.hkex.com.hk/News/Regulatory-Announcements/2023/231026news?sc_lang=en